| Write You |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Debt Relief > Help to Get Out of Debt |
|
Write You - Help to Get Out of Debt
Debt Help is the stepping stone to debt elimination and financial recovery. Debt help analysis guides you to save thousands of dollars in interest charges. Consolidation of your credit card deb According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ts and other unsecured bills will allow you to get out of debt as quickly as possible, save money on interest and late fees, stop creditor harassment, save your good credit rating or begin imme ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in diately to repair bad credit or negatives on your credit report. In a recent survey it was reported that almost 58% clients vouched for Debt Management Plan as the best way to settle their deb lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ts. Another 42% client had filed bankruptcy since dropping off a Debt Management Plan or DMP. Debt Management plans can reduce your monthly payments, interest charges, penalties and some times here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe even the repayment period. Even if bankruptcy seems like your only solution, it may not be the right debt help solution and may cost you for many years to come. The loss of a job, divorce, cre d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro dit card spending and family medical emergencies among other life style matters can cause negative money issues. Statistics released by the administrative office of U.S. Courts show that a tota ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc l of 388,864 new non-business bankruptcy filing in the United States during the quarter, ended on September 30, 2004. This included 274,196 chapter 7 filings and 114,454 chapter 13 filings. Mo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi st economists consider a ratio of unsecured debt to annual income of 40-50% percent or more, as being a strong indicator to bankruptcy. This is taken as a ‘?thumb rule’ in most of the cases. So nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically in order to protect himself from such crisis one should keep his unsecured debt to annual income ratio lower than 40 to 50%. For example if someone has an annual income of $5000, he should kee and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ p his annual debt minimum $2000 to $2500 in order to avoid his bankruptcy. 36% or less: This is a healthy debt load to carry for most people. 37%-42%: Not bad, but starts to restructure your ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi debt now before you get into real trouble. 43%-49%: Financial difficulties are likely to occur unless you take immediate action. 50% or more: Get professional help from debt counselor to agg ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ressively reduce debt. You should also control from having a large amount of unpaid outstanding credit or using more than 80% of your available credit (which causes a high debt to income ratio dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ). It is better to have a debt free life without having a savings rather than maintaining debts along with savings. The reason is simple. As the return on short term investment i.e. savings is cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin lower than the interest payable on accumulated debt, it is always advisable to pay the debt first rather than go for the short term investment. Because a repayment of single debt instantaneous tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ly may save a lot of money in future. In other word, One dollar payment is better than one dollar saving. From the Consumer Debt so published by Federal Reserve Statistical Release, it is foun t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel d that each and every year total consumer debt (both revolving and non-revolving) has an increasing trend. In 2000 and 2001, total consumer debt has a rising trend by 11.42% and 8.04% with resp ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ect to the year 1999. However, in 2002 and 2003, total consumer debt increased to 4.45% and 4.52% respectively, at a decreasing rate with respect to just previous year’s total consumer debt. A y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products s there is no specific trend in total consumer debt we may conclude that in 2005 also, the total consumer debt will have an increasing trend of 4.49% which signifies that at the end of 2005 tot . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de al consumer debt will reach about $2109.85 Billion. For better insight in this topic please view: http://www.d elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Human Resource Employee Risk Profile - Management Risks Explained
|